Yin‐Hsun Feng

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial

Cristina Saura, Mafalda Oliveira, Yin‐Hsun Feng et al. · Journal of Clinical Oncology · 2020 · 609 citations · Full text

Medicine, Oncology, Pharmacology +15

Emerging role of microRNA-21 in cancer

Yin‐Hsun Feng, Chao‐Jung Tsao · Biomedical Reports · 2016 · 454 citations · Full text

Medicine, Cancer Biology, Oncology +17

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

B. Sangro, Stephen L. Chan, Robin Kate Kelley et al. · Annals of Oncology · 2024 · 312 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma

Ghassan K. Abou‐Alfa, Shukui Qin, Baek‐Yeol Ryoo et al. · Annals of Oncology · 2018 · 255 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer

Chia-Sing Lu, Ai‐Li Shiau, Bing‐Hua Su et al. · Journal of Hematology & Oncology · 2020 · 149 citations · Full text

Life Sciences, Cell Biology, Oncology +17